Literature DB >> 11115377

Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications.

S Rossetti1, L Strmecki, V Gamble, S Burton, V Sneddon, B Peral, S Roy, A Bakkaloglu, R Komel, C G Winearls, P C Harris.   

Abstract

Mutation screening of the major autosomal dominant polycystic kidney disease (ADPKD) locus, PKD1, has proved difficult because of the large transcript and complex reiterated gene region. We have developed methods, employing long polymerase chain reaction (PCR) and specific reverse transcription-PCR, to amplify all of the PKD1 coding area. The gene was screened for mutations in 131 unrelated patients with ADPKD, using the protein-truncation test and direct sequencing. Mutations were identified in 57 families, and, including 24 previously characterized changes from this cohort, a detection rate of 52.3% was achieved in 155 families. Mutations were found in all areas of the gene, from exons 1 to 46, with no clear hotspot identified. There was no significant difference in mutation frequency between the single-copy and duplicated areas, but mutations were more than twice as frequent in the 3' half of the gene, compared with the 5' half. The majority of changes were predicted to truncate the protein through nonsense mutations (32%), insertions or deletions (29.6%), or splicing changes (6.2%), although the figures were biased by the methods employed, and, in sequenced areas, approximately 50% of all mutations were missense or in-frame. Studies elsewhere have suggested that gene conversion may be a significant cause of mutation at PKD1, but only 3 of 69 different mutations matched PKD1-like HG sequence. A relatively high rate of new PKD1 mutation was calculated, 1.8x10-5 mutations per generation, consistent with the many different mutations identified (69 in 81 pedigrees) and suggesting significant selection against mutant alleles. The mutation detection rate, in this study, of >50% is comparable to that achieved for other large multiexon genes and shows the feasibility of genetic diagnosis in this disorder.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115377      PMCID: PMC1234934          DOI: 10.1086/316939

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  69 in total

1.  Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families.

Authors:  O Z DALGAARD
Journal:  Acta Med Scand Suppl       Date:  1957

2.  A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2).

Authors:  B Veldhuisen; J J Saris; S de Haij; T Hayashi; D M Reynolds; T Mochizuki; R Elles; R Fossdal; N Bogdanova; M A van Dijk; E Coto; D Ravine; S Nørby; C Verellen-Dumoulin; M H Breuning; S Somlo; D J Peters
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  Mutation detection in the repeated part of the PKD1 gene.

Authors:  J H Roelfsema; L Spruit; J J Saris; P Chang; Y Pirson; G J van Ommen; D J Peters; M H Breuning
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

4.  Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair.

Authors:  G Wang; M M Seidman; P M Glazer
Journal:  Science       Date:  1996-02-09       Impact factor: 47.728

5.  Identification of mutations in the repeated part of the autosomal dominant polycystic kidney disease type 1 gene, PKD1, by long-range PCR.

Authors:  R Thomas; R McConnell; J Whittacker; P Kirkpatrick; J Bradley; R Sandford
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

6.  Polycystin 1 is required for the structural integrity of blood vessels.

Authors:  K Kim; I Drummond; O Ibraghimov-Beskrovnaya; K Klinger; M A Arnaout
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

7.  The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.

Authors:  F Qian; T J Watnick; L F Onuchic; G G Germino
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

8.  DNA structural transitions within the PKD1 gene.

Authors:  R T Blaszak; V Potaman; R R Sinden; J J Bissler
Journal:  Nucleic Acids Res       Date:  1999-07-01       Impact factor: 16.971

9.  Identification of a human homologue of the sea urchin receptor for egg jelly: a polycystic kidney disease-like protein.

Authors:  J Hughes; C J Ward; R Aspinwall; R Butler; P C Harris
Journal:  Hum Mol Genet       Date:  1999-03       Impact factor: 6.150

10.  Germinal and somatic mutations in the PKD2 gene of renal cysts in autosomal dominant polycystic kidney disease.

Authors:  M Koptides; C Hadjimichael; P Koupepidou; A Pierides; C Constantinou Deltas
Journal:  Hum Mol Genet       Date:  1999-03       Impact factor: 6.150

View more
  70 in total

1.  A novel long-range PCR sequencing method for genetic analysis of the entire PKD1 gene.

Authors:  Ying-Cai Tan; Alber Michaeel; Jon Blumenfeld; Stephanie Donahue; Tom Parker; Daniel Levine; Hanna Rennert
Journal:  J Mol Diagn       Date:  2012-05-16       Impact factor: 5.568

2.  Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system.

Authors:  E Parker; L J Newby; C C Sharpe; S Rossetti; A J Streets; P C Harris; M J O'Hare; A C M Ong
Journal:  Kidney Int       Date:  2007-03-28       Impact factor: 10.612

3.  High-resolution melt as a screening method in autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Grazia Maria Virzì; Alice Bruson; Valentina Corradi; Fiorella Gastaldon; Massimo de Cal; Marta Donà; Dinna N Cruz; Maurizio Clementi; Claudio Ronco
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

Review 4.  ADPKD: molecular characterization and quest for treatment.

Authors:  Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

5.  Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease.

Authors:  Katharina Hopp; Emilie Cornec-Le Gall; Sarah R Senum; Iris B A W Te Paske; Sonam Raj; Sravanthi Lavu; Saurabh Baheti; Marie E Edwards; Charles D Madsen; Christina M Heyer; Albert C M Ong; Kyongtae T Bae; Richard Fatica; Theodore I Steinman; Arlene B Chapman; Berenice Gitomer; Ronald D Perrone; Frederic F Rahbari-Oskoui; Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2019-10-09       Impact factor: 10.612

6.  Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney disease.

Authors:  Amali C Mallawaarachchi; Yvonne Hort; Mark J Cowley; Mark J McCabe; André Minoche; Marcel E Dinger; John Shine; Timothy J Furlong
Journal:  Eur J Hum Genet       Date:  2016-05-11       Impact factor: 4.246

7.  Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations.

Authors:  Feng Qian; Alessandra Boletta; Anil K Bhunia; Hangxue Xu; Lijuan Liu; Ali K Ahrabi; Terry J Watnick; Fang Zhou; Gregory G Germino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

Review 8.  Molecular diagnostics for autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Sandro Rossetti
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

9.  Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease.

Authors:  Miguel A Garcia-Gonzalez; Jeffrey G Jones; Susan K Allen; Christopher M Palatucci; Sat D Batish; William K Seltzer; Zheng Lan; Erica Allen; Feng Qian; Xose M Lens; York Pei; Gregory G Germino; Terry J Watnick
Journal:  Mol Genet Metab       Date:  2007-06-18       Impact factor: 4.797

10.  Naturally occurring mutations alter the stability of polycystin-1 polycystic kidney disease (PKD) domains.

Authors:  Liang Ma; Meixiang Xu; Julia R Forman; Jane Clarke; Andres F Oberhauser
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.